CIK: 1410781 - Address: C/O Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL 60607
15 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret315517164929762
P%wins8060404010010070
S%ret11101-3000-1
S%wins100010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/15/25 16:57
8/13/25
XERSXeris Biopharma Holdings, Inc.HealthDrugPharmaceutical PreparationsJohnson JohnILDS-7867.320-108-11833D
6/11/25 16:23
6/9/25
AXGNAxogen, Inc.MNHealthElcMdElectromedical & ElectrotheraJohnson JohnFLDS-4310.610-4-1425D
9/4/24 21:13
9/1/24
AXGNAxogen, Inc.MNHealthElcMdElectromedical & ElectrotheraJohnson JohnFLDM.d00.000127029D
3/18/24 17:32
3/18/24
XERSXeris Biopharma Holdings, Inc.HealthDrugPharmaceutical PreparationsJohnson JohnILDM.d4291.99021640751D
6/5/23 18:53
6/1/23
AXGNAxogen, Inc.MNHealthElcMdElectromedical & ElectrotheraJohnson JohnFLDM.d00.0006New6D
7/2/19 21:09
6/27/19
MLNTMelinta Therapeutics, Inc. /new/DEHealthDrugPharmaceutical PreparationsJohnson JohnNJDOCEOS-725.570-13-2637D
6/26/19 16:06
5/22/19
MLNTMelinta Therapeutics, Inc. /new/DEHealthDrugPharmaceutical PreparationsJohnson JohnNCDM.d00.00050999%50D
5/28/14 17:23
5/23/14
CEMPCempra, Inc.DEHealthDrugPharmaceutical PreparationsJohnson JohnNCDP.d919.10210New10D3729-26-3242726-319749297
1/4/12 16:17
1/3/12
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicJohnson JohnNJDOCEOS-412.304-18-7252D-84-80-69-38-263801-3
11/22/11 18:40
11/21/11
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicJohnson JohnNJDOCEO,PP122.30552270D-82-79-67-39-34-28-7-1-32-4-8
11/21/11 12:06
11/18/11
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicJohnson JohnNJDOCEO,PP252.295114269M-83-81-70-39-39-37-21-87-3-5-10
11/7/11 17:50
11/4/11
DNDNDendreon CorpDEHealthDrugPharmaceutical PreparationsJohnson JohnWADP176.683332413D-76-81-83-35-34-28-33-379829139
9/16/11 19:05
9/14/11
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicJohnson JohnNJDOCEO,PP.m1144.0962812258M-74-80-56-41-11611860-3-50
8/28/08 17:34
8/27/08
IMCLImclone Systems IncDEHealthBioPrdBiological Products, (No DiagJohnson John HNYDOCEOM.d00.00087219D
9/10/07 14:07
9/7/07
IMCLImclone Systems IncDEHealthBioPrdBiological Products, (No DiagJohnson John HNYOCEOP50036.74014New14D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact